Article
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential
11 Jul 2018
Abstract excerpt
We have shown that antagomiR inhibition of miRNA miR-21 and miR-196b activity is sufficient to ablate MLL-AF9 leukemia stem cells (LSC) in vivo. Here, we used an shRNA screening approach to mimic miRNA activity on experimentally verified miR-196b targets to identify functionally important and therapeutically relevant pathways downstream of oncogenic miRNA in MLL-r AML. We found Cdkn1b (p27Kip1) is a direct...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
